Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Locarnini

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Antiviral Research|June 1, 1993
The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virusJ Niu, Y Wang, R Dixon, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 1, 1996
Retransplantation for precore mutant-related chronic hepatitis B infection: prolonged survival in a patient receiving sequential ganciclovir/famciclovir therapyG McCaughan, P Angus, S Bowden, et al.
Journal of Virology|June 1, 1995
The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomesJ E Newbold, H Xin, M Tencza, et al.
Journal of Medical Virology|June 1, 1990
Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compoundsG Civitico, Y Y Wang, C Luscombe, et al.
Journal of Molecular Biology|March 13, 2001
Structural organization of the hepatitis B virus minichromosomeC T Bock, S Schwinn, S Locarnini, et al.
Journal of Medical Virology|June 1, 1990
Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus modelN Bishop, G Civitico, Y Y Wang, et al.
Journal of Hepatology|May 1, 1997
Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantationT T Aye, A Bartholomeusz, T Shaw, et al.
Antiviral Research|August 1, 1994
Use of a flavivirus RNA-dependent RNA polymerase assay to investigate the antiviral activity of selected compoundsA Bartholomeusz, E Tomlinson, P J Wright, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 7, 2006
Toll-like receptor expression in chronic hepatitis C: correlation with pro-inflammatory cytokine levels and liver injuryS M Riordan, N A Skinner, J Kurtovic, et al.
Hepatology (Baltimore, Md.)|October 27, 2001
Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observedS R Lewin, R M Ribeiro, T Walters, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Antiviral Research|June 1, 1993
The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virusJ Niu, Y Wang, R Dixon, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 1, 1996
Retransplantation for precore mutant-related chronic hepatitis B infection: prolonged survival in a patient receiving sequential ganciclovir/famciclovir therapyG McCaughan, P Angus, S Bowden, et al.
Journal of Virology|June 1, 1995
The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomesJ E Newbold, H Xin, M Tencza, et al.
Journal of Medical Virology|June 1, 1990
Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compoundsG Civitico, Y Y Wang, C Luscombe, et al.
Journal of Molecular Biology|March 13, 2001
Structural organization of the hepatitis B virus minichromosomeC T Bock, S Schwinn, S Locarnini, et al.
Journal of Medical Virology|June 1, 1990
Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus modelN Bishop, G Civitico, Y Y Wang, et al.
Journal of Hepatology|May 1, 1997
Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantationT T Aye, A Bartholomeusz, T Shaw, et al.
Antiviral Research|August 1, 1994
Use of a flavivirus RNA-dependent RNA polymerase assay to investigate the antiviral activity of selected compoundsA Bartholomeusz, E Tomlinson, P J Wright, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 7, 2006
Toll-like receptor expression in chronic hepatitis C: correlation with pro-inflammatory cytokine levels and liver injuryS M Riordan, N A Skinner, J Kurtovic, et al.
Hepatology (Baltimore, Md.)|October 27, 2001
Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observedS R Lewin, R M Ribeiro, T Walters, et al.
Pageof 7